Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy for acute ischemic stroke

N J Solenski1

  • 1UVa Health Sciences Center, Department of Neurology, Charlottesville 22908, USA. njs2j@virginia.edu

Virginia Medical Quarterly : VMQ
|May 13, 1998
PubMed
Summary

Thrombolytic therapy offers a revolutionary, clinically proven treatment to improve outcomes for acute ischemic stroke. This advancement necessitates rapid, multidisciplinary care and highlights the primary care physician's crucial role in prevention and patient education.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide.

Biochemical and biophysical research communications·2001
Same author

Cerebral ischemia-reperfusion injury: a novel therapeutic approach with TAK-218.

Clinical neuropharmacology·2000
Same author

Attenuation of free radical generation during reversible focal cerebral ischemia with the nitric oxide inhibitor, L-NAME (L-N(G)-nitro-L-arginine methyl ester).

Brain research·2000
Same author

Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia.

Stroke·1997
Same author

Hemolysate induces structural and functional injury to cultured cerebral endothelial cells.

The Kaohsiung journal of medical sciences·1997
Same author

Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium.

Acta neurochirurgica·1997

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute stroke management has historically lacked effective interventions.
  • The emergence of thrombolytic therapy marks a significant paradigm shift in stroke care.
  • Timely intervention is critical for improving patient prognosis in acute stroke.

Purpose of the Study:

  • To highlight the revolutionary impact of thrombolytic therapy in acute stroke treatment.
  • To emphasize the need for a rapid, multidisciplinary approach to stroke management.
  • To define the essential role of primary care physicians in stroke prevention and acute care coordination.

Main Methods:

  • Review of the clinical impact and implementation of thrombolytic therapy for acute ischemic stroke.
  • Discussion of the organizational changes required for effective acute stroke treatment, including specialized teams and centers.
  • Emphasis on the primary care physician's role in patient education and pathway to acute care.

Main Results:

  • Thrombolytic therapy is the first clinically proven treatment to improve outcomes in acute ischemic stroke.
  • The availability of effective acute stroke therapies is expanding, ushering in a new era of treatment.
  • Multidisciplinary teams and designated stroke centers are essential for delivering rapid, appropriate care.

Conclusions:

  • Thrombolytic therapy represents a major advancement in acute stroke treatment, significantly improving patient outcomes.
  • Effective stroke management requires a coordinated, rapid response system involving specialized teams and centers.
  • Primary care physicians are integral to stroke prevention, early recognition, and guiding patients to timely, acute treatment.

Related Experiment Videos